Zobrazeno 1 - 2
of 2
pro vyhledávání: '"M. A. Psotka"'
Autor:
M. Metra, M. A. Psotka, Christopher M. O'Connor, C Perego, Claudia Specchia, Lee-Jen Wei, M Sbolli, Mona Fiuzat, Giulia Peveri, Chiara Oriecuia
Publikováno v:
European Heart Journal. 41
Background The hazard ratio (HR) is the most common measure used to quantify treatment effects in heart failure (HF) clinical trials. However, the HR is only valid when the proportional hazards assumption is plausible, and the HR may be difficult to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b015305e724b2bec5367355785f9f6a5
https://doi.org/10.1093/ehjci/ehaa946.1039
https://doi.org/10.1093/ehjci/ehaa946.1039
Autor:
M. A. Psotka, G.M. Felker, S. S. Sinha, Mona Fiuzat, Norman Stockbridge, Christopher M. O'Connor, M. Bruckmann, John R. Teerlink, Mary M. DeSouza, Scott D. Solomon, S. D. Barnett, Marvin A. Konstam, Javed Butler, Ellis F. Unger
AimsClinical trial inefficiency and lack of patient access to novel therapies have been identified as key barriers to successful heart failure innovation. The Heart Failure Collaboratory (HFC) is a consortium developed to identify and address barrier
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2e7027ebe6b79f8d10c3865a0eff388
https://doi.org/10.1101/2020.06.24.20124917
https://doi.org/10.1101/2020.06.24.20124917
